Considerations for Future SARS-CoV-2 Vaccines: A Private Sector Perspective

May 12, 2020

Several vaccine candidates are being tested to help address the ongoing COVID-19 pandemic. Uncertainty remains about key epidemiologic factors to characterize the disease, including true infection rate, proportion of symptomatic cases, and potential for re-infection. As the virus spreads and data continue to develop, the potential role of vaccination will continue to evolve. This presentation will describe some of the data needed to inform vaccination strategies, as well as guide the development and manufacture of future vaccines. Partnerships between public, private, and academic research groups will be essential to ensure rapid and fair deployment of future vaccines, define a research agenda, and balance supply and demand in the early phases of vaccine availability.

Registration is open here.

You May Also Like

Advancing Local Solutions and Innovations for Lasting Impact: Applying Strategies for COVID-19 Vaccination to Routine Immunisation

11/30/2023

Wilson Center’s Maternal Health Initiative, in collaboration with MOMENTUM Routine Immunization Transformation and Equity project are holding an event sharing best practices and innovations used to achieve high equitable coverage of COVID-19 vaccination and reach hard-to-reach priority populations, and how they could be applied to routine immunization. When: Wednesday, December 6th, 2023 from 9:30 – … Read More

Learning exchange webinar: Targeted assessments for identifying zero-dose and under-immunised children

11/15/2023

MOMENTUM Routine Immunization Transformation and Equity is pleased to invite you to a webinar on November 15, 2023, at 8:00 am ET (13:00 pm GMT) to discuss targeted assessments for identifying zero-dose and under-immunised children. Reducing the number of zero-dose and under-immunised children requires accurate, specific data on these populations, and managers and implementers of … Read More

Gavi Talks: Finding Zero-Dose Children

10/16/2023

 16 October, 3-4pm CET / 9am EST/ 4pm EAT Join two back-to-back sessions to learn about the findings from Gavi-commissioned studies, leveraging data and analytics to reach zero-dose children more effectively. Session one: finding zero-dose children using predictive algorithms (3-3:30pm CET) Harvard researchers commissioned by Gavi have completed a first of its kind study to … Read More